Annual EBIT
$65.48 M
+$68.39 M+2347.79%
December 31, 2022
Summary
- As of February 8, 2025, EGRX annual earnings before interest & taxes is $65.48 million, with the most recent change of +$68.39 million (+2347.79%) on December 31, 2022.
- During the last 3 years, EGRX annual EBIT has risen by +$40.79 million (+165.26%).
- EGRX annual EBIT is now -11.61% below its all-time high of $74.08 million, reached on December 31, 2017.
Performance
EGRX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
$10.75 M
-$1.00 M-8.52%
June 30, 2023
Summary
- As of February 8, 2025, EGRX quarterly earnings before interest & taxes is $10.75 million, with the most recent change of -$1.00 million (-8.52%) on June 30, 2023.
- Over the past year, EGRX quarterly EBIT has increased by +$16.06 million (+302.14%).
- EGRX quarterly EBIT is now -81.48% below its all-time high of $58.03 million, reached on March 31, 2022.
Performance
EGRX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
$35.66 M
+$16.06 M+81.96%
June 30, 2023
Summary
- As of February 8, 2025, EGRX TTM earnings before interest & taxes is $35.66 million, with the most recent change of +$16.06 million (+81.96%) on June 30, 2023.
- Over the past year, EGRX TTM EBIT has dropped by -$6.41 million (-15.23%).
- EGRX TTM EBIT is now -61.20% below its all-time high of $91.89 million, reached on September 30, 2017.
Performance
EGRX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
EGRX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2347.8% | +302.1% | -15.2% |
| 3 y3 years | +165.3% | +74.5% | +476.0% |
| 5 y5 years | -11.6% | +5740.2% | +44.5% |
EGRX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2347.8% | -81.5% | +302.1% | -45.9% | +1324.1% |
| 5 y | 5-year | at high | +2347.8% | -81.5% | +187.6% | -45.9% | +1324.1% |
| alltime | all time | -11.6% | +429.8% | -81.5% | +187.6% | -61.2% | +258.0% |
Eagle Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $10.75 M(-8.5%) | $35.66 M(+82.0%) |
| Mar 2023 | - | $11.75 M(-22.9%) | $19.60 M(-70.3%) |
| Dec 2022 | $65.48 M(-2347.8%) | $15.24 M(-835.4%) | $65.88 M(+26.1%) |
| Sep 2022 | - | -$2.07 M(-61.0%) | $52.26 M(+24.2%) |
| Jun 2022 | - | -$5.32 M(-109.2%) | $42.06 M(-21.2%) |
| Mar 2022 | - | $58.03 M(+3484.1%) | $53.35 M(-1931.5%) |
| Dec 2021 | -$2.91 M(-111.5%) | $1.62 M(-113.2%) | -$2.91 M(-140.1%) |
| Sep 2021 | - | -$12.26 M(-305.4%) | $7.27 M(-74.9%) |
| Jun 2021 | - | $5.97 M(+238.8%) | $28.95 M(-0.6%) |
| Mar 2021 | - | $1.76 M(-85.1%) | $29.14 M(+15.4%) |
| Dec 2020 | $25.25 M(+2.3%) | $11.80 M(+25.3%) | $25.25 M(+44.2%) |
| Sep 2020 | - | $9.41 M(+52.8%) | $17.52 M(+183.0%) |
| Jun 2020 | - | $6.16 M(-390.7%) | $6.19 M(-37.5%) |
| Mar 2020 | - | -$2.12 M(-152.1%) | $9.90 M(-59.9%) |
| Dec 2019 | $24.68 M(-32.9%) | $4.07 M(-312.4%) | $24.68 M(-32.3%) |
| Sep 2019 | - | -$1.91 M(-119.4%) | $36.47 M(-35.8%) |
| Jun 2019 | - | $9.87 M(-22.1%) | $56.80 M(+20.6%) |
| Mar 2019 | - | $12.66 M(-20.1%) | $47.11 M(+28.1%) |
| Dec 2018 | $36.77 M(-50.4%) | $15.85 M(-13.9%) | $36.78 M(+17.1%) |
| Sep 2018 | - | $18.41 M(>+9900.0%) | $31.41 M(-17.3%) |
| Jun 2018 | - | $184.00 K(-92.1%) | $37.98 M(-13.1%) |
| Mar 2018 | - | $2.33 M(-77.8%) | $43.71 M(-41.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $74.08 M(+38.6%) | $10.48 M(-58.1%) | $74.08 M(-19.4%) |
| Sep 2017 | - | $24.98 M(+322.3%) | $91.89 M(+16.0%) |
| Jun 2017 | - | $5.92 M(-81.9%) | $79.24 M(-8.9%) |
| Mar 2017 | - | $32.70 M(+15.6%) | $87.01 M(+62.8%) |
| Dec 2016 | $53.44 M(+1967.1%) | $28.29 M(+129.4%) | $53.44 M(+102.9%) |
| Sep 2016 | - | $12.33 M(-9.9%) | $26.34 M(+626.4%) |
| Jun 2016 | - | $13.69 M(-1662.3%) | $3.63 M(-119.7%) |
| Mar 2016 | - | -$876.00 K(-173.2%) | -$18.39 M(-811.0%) |
| Dec 2015 | $2.58 M(-113.4%) | $1.20 M(-111.5%) | $2.59 M(-150.0%) |
| Sep 2015 | - | -$10.38 M(+24.7%) | -$5.17 M(+32.8%) |
| Jun 2015 | - | -$8.33 M(-141.4%) | -$3.90 M(-359.4%) |
| Mar 2015 | - | $20.10 M(-406.2%) | $1.50 M(-106.7%) |
| Dec 2014 | - | -$6.56 M(-27.9%) | -$22.57 M(+17.2%) |
| Sep 2014 | -$19.26 M(+247.3%) | -$9.10 M(+210.7%) | -$19.26 M(+99.0%) |
| Jun 2014 | - | -$2.93 M(-26.4%) | -$9.68 M(+74.6%) |
| Mar 2014 | - | -$3.98 M(+22.2%) | -$5.54 M(-6.0%) |
| Dec 2013 | - | -$3.25 M(-773.2%) | -$5.90 M(+6.3%) |
| Sep 2013 | -$5.55 M(-72.1%) | $483.50 K(-59.9%) | -$5.55 M(-8.0%) |
| Jun 2013 | - | $1.21 M(-127.9%) | -$6.03 M(-16.7%) |
| Mar 2013 | - | -$4.33 M(+49.1%) | -$7.24 M(+149.1%) |
| Dec 2012 | - | -$2.91 M | -$2.91 M |
| Sep 2012 | -$19.86 M | - | - |
FAQ
- What is Eagle Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals annual EBIT year-on-year change?
- What is Eagle Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals quarterly EBIT year-on-year change?
- What is Eagle Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals TTM EBIT year-on-year change?
What is Eagle Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of EGRX is $65.48 M
What is the all time high annual EBIT for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high annual earnings before interest & taxes is $74.08 M
What is Eagle Pharmaceuticals annual EBIT year-on-year change?
Over the past year, EGRX annual earnings before interest & taxes has changed by +$68.39 M (+2347.79%)
What is Eagle Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of EGRX is $10.75 M
What is the all time high quarterly EBIT for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high quarterly earnings before interest & taxes is $58.03 M
What is Eagle Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, EGRX quarterly earnings before interest & taxes has changed by +$16.06 M (+302.14%)
What is Eagle Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of EGRX is $35.66 M
What is the all time high TTM EBIT for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high TTM earnings before interest & taxes is $91.89 M
What is Eagle Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, EGRX TTM earnings before interest & taxes has changed by -$6.41 M (-15.23%)